Clinical trials for lung cancer
130 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Lung cancer
#NCT04339218
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Metastatic
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Institut Bergonié
Phase 3
Lung cancer
#NCT05170204
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
ALK
Systemic Treatment-Naive
EGFR
Immunotherapy
Targeted therapy
Immunotherapy
Targeted therapy
Hôpital d'Instruction des Armées Sainte-Anne (Toulon), Centre Hospitalier Universitaire de Toulouse (Toulouse), Hôpital Nord de Marseille (Marseille Cedex 20), Centre François Baclesse (Caen ), Centre Léon Bérard (Lyon) (and 3 more...)
Hoffmann-La Roche
Phase 3
Lung cancer
#NCT05048797
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
HER2
Systemic Treatment-Naive
ALK
EGFR
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Centre hospitalier universitaire François Mitterrand (Dijon), Centre Hospitalier du Mans (Le Mans), Hôpital Nord de Marseille (Marseille Cedex 20) (and 2 more...)
AstraZeneca
Phase 3
Lung cancer
#NCT05078047
Metastatic
Immunotherapy
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Henri-Mondor AP-HP (Créteil) (and 14 more...)
UNICANCER
Phase 3
Lung cancer
#NCT05111197
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Immunotherapy
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers )
Institut de Cancérologie de l'Ouest
Phase 3
Lung cancer
#NCT05261399
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
MET
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire Angers (Angers ), Hôpital Avicenne - AP-HP (Bobigny), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ) (and 10 more...)
AstraZeneca
Phase 3
Lung cancer
#NCT06140836
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
EGFR
BRAF
MET
HER2
ALK
RET
KRAS G12C
KRAS non G12C
PIK3CA
NTRK-1/2/3
Targeted therapy
Targeted therapy
Centre Hospitalier Universitaire Laennec (Saint-Herblain), Hôpital Cochin (Paris ), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre hospitalier universitaire François Mitterrand (Dijon) (and 3 more...)
Bristol-Myers Squibb
Phase 2 / Phase 3
Lung cancer
#NCT05255302
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Metastatic
Systemic Treatment-Naive
ALK
Other mutation
EGFR
HER2
NTRK-1/2/3
RET
ROS-1
Chemotherapy
Immunotherapy
Chemotherapy
Immunotherapy
Targeted therapy
Hôpital Bichat - Claude Bernard - AP-HP (Paris), CHU Caen Normandie (Caen), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
#NCT03767075
Locally Advanced
Metastatic
Metastatic Castration-resistant
Systemic Treatment-Naive
Gustave Roussy (Villejuif)
Institut d'oncologie du Vall d'Hebron
Phase 2
Lung cancer
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
#NCT06162221
KRAS G12C
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Hôpital Louis Pradel (Bron ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille), Centre Hospitalier Universitaire de Nantes (Nantes) (and 1 more...)
Revolution Medicines, Inc.